| DB ID | MyCo_5376 |
| Title | Inflammation-related indices as markers for mortality in people living with HIV co-infected with Talaromyces Marneffei: a retrospective analysis |
| Year | 2025 |
| PMID | 40287401 |
| Fungal Diseases involved | Talaromyces marneffei infection |
| Associated Medical Condition | None |
| Genus | Talaromyces |
| Species | marneffei |
| Organism | Talaromyces marneffei |
| Ethical Statement | The study was approved by the Ethics Committee of Nan- fang Hospital, Southern Medical University (study identifier: NFEC-2021-448), and adhered to the principles of the 1964 Helsinki Declaration and its amendments. |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Blood |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | NLR |
| Biomarker Full Name | Neutrophil-to-lymphocyte ratio |
| Biomarker Type | Predictive |
| Biomolecule | None |
| Geographical Location | China |
| Cohort | A total of 282 participants were in- cluded, recruited from two medical centers: Nanfang Hospi-tal,Southern Medical University,and The First People’s Hos- pitalofFoshan. |
| Cohort No. | 282 |
| Age Group | None |
| P Value | p<0.001 |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Analytic |
| Analysis Method | neutrophil-to-lymphocyte ratio Analysis |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | neutrophil-to-lymphocyte ratio Analysis, neutrophil-to-platelet ratio Analysis |
| Up Regulation Down Regulation | Positive |
| Sequence Data | None |
| External Link | None |
